Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer's Disease: Phase 3 Study Design
Abstract
Abstract is not available.Similar works
Full text
Available Versions
Last time updated on 30/03/2019